β-hydroxy-β-methylbutyrate enhances anti-PD1 immunotherapy in a mouse model of pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Etigunta, Suhas K. [1 ]
Coleman, Michael F. [1 ]
Pfeil, Alex J. [1 ]
Lashinger, Laura M. [2 ]
Cui, Zhengrong [2 ]
Hursting, Stephen D. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Univ Texas Austin, Austin, TX 78712 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1565
引用
收藏
页数：2
相关论文
共 50 条
  • [1] β-Hydroxy-β-methylbutyrate (HMB) sensitizes murine pancreatic ductal adenocarcinoma (PDAC) to immunotherapy
    Etigunta, Suhas K.
    Coleman, Michael F.
    Liu, Kristyn A.
    Pfeil, Alex J.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma
    Coleman, Michael F.
    Liu, Kristyn A.
    Pfeil, Alexander J.
    Etigunta, Suhas K.
    Tang, Xiaohu
    Fabela, Salvador
    Lashinger, Laura M.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCERS, 2021, 13 (24)
  • [3] β-Hydroxy-β-methylbutyrate promotes immunotherapy response and pro-inflammatory macrophage polarization in a mouse model of pancreatic cancer
    Coleman, Michael F.
    Liu, Kristyn A.
    Pfeil, Alexander J.
    Etigunta, Suhas K.
    Tang, Xiaohu
    Lashinger, Laura M.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCER RESEARCH, 2022, 82 (12)
  • [4] Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
    Liu, Jing
    Jiang, Wenna
    Zhao, Kaili
    Wang, Hongwei
    Zhou, Tianxing
    Bai, Weiwei
    Wang, Xiuchao
    Zhao, Tiansuo
    Huang, Chongbiao
    Gao, Song
    Qin, Tai
    Yu, Wenwen
    Yang, Bo
    Li, Xin
    Fu, Danqi
    Tan, Wei
    Yang, Shengyu
    Ren, He
    Hao, Jihui
    JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (03): : 656 - 673
  • [5] Auranofin enhances the efficacy of anti-PD1 immunotherapy
    Zhao, Zichen
    Hu, Shichuan
    Zhang, Yan
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Polymerase theta inhibition synergizes with anti-PD-1 immunotherapy in BRCA2-deficient pancreatic ductal adenocarcinoma.
    Patterson-Fortin, Jeffrey
    Jadhav, Heta
    Pantelidou, Constantia
    Phan, Tin
    Grochala, Carter
    Hao, Jie
    Wang, Junning
    Andrews, Elizabeth A.
    Guerriero, Jennifer L.
    Wolpin, Brian M.
    Stanger, Ben Z.
    Aguirre, Andrew A.
    Cleary, James M.
    D'Andrea, Alan A.
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2022, 82 (22) : 117 - 118
  • [7] β Hydroxy β Methylbutyrate synergizes with cytotoxic chemotherapy and immunotherapy in a mouse model of pancreatic cancer.
    Coleman, Michael F.
    Liu, Kristyn A.
    Etigunta, Suhas K.
    Pfeil, Alex J.
    Tang, Xiaohu
    Fabela, Salvador
    Lashinger, Laura M.
    Cui, Zhengrong
    Hursting, Stephen D.
    CANCER RESEARCH, 2021, 81 (13)
  • [8] A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model
    Wei, Yuhua
    Wang, Yufeng
    Liu, Nanbin
    Qi, Ran
    Xu, Yan
    Li, Kun
    Feng, Yu
    Shi, Baomin
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [9] Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma
    Yang, Jia
    Hu, Su
    Shangguan, Junjie
    Eresen, Aydin
    Li, Yu
    Pan, Liang
    Ma, Quanhong
    Velichko, Yuri
    Wang, Jian
    Hu, Chunhong
    Yaghmai, Vahid
    Zhang, Zhuoli
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (11): : 2456 - +
  • [10] Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model
    Said Ahmed Bahwal
    Jane J. Chen
    Lilin E
    Taofang Hao
    Jiancong Chen
    Vern B. Carruthers
    Jiaming Lai
    Xingwang Zhou
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2743 - 2757
12345